Sign in to view content

Obstructive Sleep Apnea is an Important Cause of Retinopathy and Recalcitrant Retinal Vascular Disease

Robert Andrew Sisk, MD, FACS, FASRS

Video
Published 2021

Related

ZETA-1 Phase 2 Trial Safety and Tolerability Results for APX3330 a New Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy
Daniel Su, MD
Annual Meeting Talks
2023
Obstructive Sleep Apnea as a Risk Factor for Diabetic Retinopathy Progression and Systemic Complications
Ehsan Rahimy, MD
Annual Meeting Talks
2024
Treatment of CRVO: SCORE2 Sub-analysis
Michael S. Ip, MD
Updates from the Field
2019

Category: Retinal Vascular Disease

See more